DENGUE
Clinical trials for DENGUE explained in plain language.
Never miss a new study
Get alerted when new DENGUE trials appear
Sign up with your email to follow new studies for DENGUE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can an arthritis drug tame Dengue's deadly inflammation?
Disease control OngoingThis study tests whether anakinra, a drug that reduces inflammation, can help people hospitalized with severe dengue who have very high levels of a marker called ferritin. About 160 patients will receive either anakinra or a placebo, and doctors will track how their organ functio…
Matched conditions: DENGUE
Phase: PHASE2 • Sponsor: Oxford University Clinical Research Unit, Vietnam • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
800,000 dengue vaccine recipients studied in vietnam
Knowledge-focused OngoingThis study looks at the health records of up to 800,000 people who received the TAK-003 (Qdenga) dengue vaccine at VNVC centers in Vietnam. Researchers want to describe who got the vaccine, including their age, sex, and where they live. No new tests or visits are needed—only exis…
Matched conditions: DENGUE
Sponsor: Tam Anh Research Institute • Aim: Knowledge-focused
Last updated May 17, 2026 11:36 UTC
-
How your daily commute could help stop dengue
Knowledge-focused OngoingThis study aims to improve how we predict and prevent dengue outbreaks by looking at how people move around a city in Cuba. Researchers will combine information on daily travel, schools, workplaces, and environmental risks with past dengue data. The goal is to create better compu…
Matched conditions: DENGUE
Sponsor: Institute of Tropical Medicine, Belgium • Aim: Knowledge-focused
Last updated May 17, 2026 11:34 UTC
-
Dengue vaccine study seeks clues in immune cells
Knowledge-focused OngoingThis study aims to understand how T-cells (a type of immune cell) respond to the Takeda dengue vaccine. Researchers will analyze blood samples from 30 healthy adults before and after vaccination to identify markers that may predict protection. The goal is to learn more about the …
Matched conditions: DENGUE
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated May 13, 2026 15:58 UTC